Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraven House Capital Regulatory News (CRV)

Share Price Information for Craven House Capital (CRV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.20
Bid: 0.15
Ask: 0.25
Change: 0.00 (0.00%)
Spread: 0.10 (66.667%)
Open: 0.20
High: 0.20
Low: 0.20
Prev. Close: 0.20
CRV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Replacement - Board Changes

5 Oct 2016 16:12

RNS Number : 8089L
Craven House Capital PLC
05 October 2016
 

 

 

The issuer advises that the following replaces the Board Changes announcement released on 4 October at 07:00 BST.

 

Under "Additional information on Richard Burrows", existing shareholding in the Company has been added.

 

All other details remain unchanged.

 

The full corrected version is shown below.

 

5 October 2016

 

 

 Craven House Capital plc

 

("Craven House" or the "Company")

 

Board Changes

 

Craven House Capital (AIM:CRV) announces that Mr. Richard Burrows has been appointed to the Board of the Company as Chairman with immediate effect. Acting Chairman, Mr. Mark Pajak, will remain on the Board as Non-Executive Director.

 

Mr. Burrows brings considerable experience to the Board, having spent over 35 years leading successful businesses in a diverse range of sectors from consumer goods to banking and financial services and will offer the benefit of extensive international experience in both developed and emerging markets. Mr. Burrows is currently Chairman of British American Tobacco Plc and Non-Executive Director at Rentokil Initial Plc and Carlsberg A/S.

 

Outgoing Chairman, Mark Pajak commented, "Craven House Capital shareholders are fortunate to have such a seasoned professional as Chairman as we continue to grow the Company. Mr. Burrows' extensive experience in our target markets and his relationships will be invaluable to the Company."  

 

Mr. Burrows commented, "I am very pleased to join the Board of Craven House Capital. The Company's philosophy and strategy should provide an exciting opportunity for shareholders and I look forward to working with the Board and management to expand and grow the business."

 

Mr. Burrows is a qualified accountant. His executive career has been with Irish Distillers, where he was Chief Executive from 1978 to 2000 and at Pernod Ricard, where he was Co-Chief Executive from 2000 to 2005. He has been Chairman of British American Tobacco since 2009 and prior to that served as director, then Governor, of Bank of Ireland from 2000 to 2009.

 

Information in respect of Mr. Burrows as required by Schedule 2(g) of the AIM Rules for Companies is included below.

~ Ends ~

 

 

For further information please contact:

 

Craven House Capital Plc

Mark Pajak

www.Cravenhousecapital.com

 

Tel: 020 7002 1027

 

SI Capital

Broker

Nick Emerson

www.sicapital.co.uk

Tel: 01483 413500

 

SPARK Advisory Partners Limited

Nominated Adviser

Matt Davis/Mark Brady

www.Sparkadvisorypartners.com

 

Tel: 0203 368 3550

 

 

Additional information on Richard Burrows:

 

Full name: Richard George William Burrows

Age: 70

 

Current Directorships / Partnerships:

British American Tobacco PLC

Carlsberg AS

Rentokil Initial PLC

 

Previous Directorships / Partnerships in the last 5 years:

Eurasian Natural Resources Corporation Limited

Voicesage Global Holdings Ltd.

 

Shareholding in the Company: 1,000 ordinary shares (representing 0.04% of the total issued share capital)

 

There is no further information required to be disclosed in respect of the above appointment pursuant to Schedule 2(g) of the AIM Rules for Companies.

 

About Craven House Capital:

 

Craven House Capital is a frontier and emerging market focused merchant bank seeking value oriented long term investments. Craven House invests in all segments of the capital structure in partnership with local entrepreneurs and the local business community. Craven House provides long term patient capital and is often involved in restructuring, expansion and turn around investments in crisis and transitioning economies.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAMMMGGKKGGVZM
Date   Source Headline
28th Feb 20247:00 amRNSInterim Results
4th Jan 20247:00 amRNSResult of Annual General Meeting
29th Nov 20232:48 pmRNSAnnual Results for year ended 31 May 2023
28th Nov 20234:08 pmRNSInvestee Companies' Update
16th Nov 20239:07 amRNSInvestee Companies’ Update: Garimon and Honeydog
23rd Oct 20237:00 amRNSInvestee company update: Bio Vitos
17th Oct 20237:46 amRNSInvestee Companies’ Update: Garimon and Honeydog
29th Aug 20231:34 pmRNSInvestee company update: Bio Vitos
3rd Jul 20231:32 pmRNSInvestee company update: Bio Vitos
3rd Mar 20236:15 pmRNSPortfolio Update
27th Feb 20233:30 pmRNSInterim Results
8th Feb 20237:00 amRNSInvestee company update: Bio Vitos
27th Jan 202311:33 amRNSResult of Annual General Meeting
29th Nov 20227:00 amRNSAnnual Results for Year Ended 31 May 2022
15th Nov 20222:42 pmRNSInvestee company update: Garimon Ltd
23rd Feb 20223:01 pmRNSInterim Results
21st Jan 202212:45 pmRNSResult of AGM
23rd Dec 20213:59 pmRNSNotice of AGM
29th Nov 20216:29 pmRNSAnnual Results for year ended 31 May 2021
24th Nov 20212:55 pmRNSInvestee company update: OneBas.Com Ltd.
26th Oct 20217:00 amRNSInvestee company update: YRRO Ltd
16th Mar 20211:06 pmRNSTR-1: Notification of major holdings
18th Feb 20213:07 pmRNSInterim Results
11th Feb 202111:21 amRNSTR-1: Notification of major holdings
5th Feb 202110:44 amRNSStatement Regarding Share Price Movement
18th Jan 20212:49 pmRNSResult of Annual General Meeting
21st Dec 20207:00 amRNSNotice of General Meeting
9th Dec 20207:00 amRNSInvestee Company Update: YRRO Ltd
3rd Dec 202012:43 pmRNSAnnual Results for year ended 31 May 2020
9th Nov 20209:45 amRNSChange of Auditor
9th Oct 20203:14 pmRNSTrading Update, Change of Auditor & 2020 Results
18th Sep 202010:57 amRNSInvestee company update: Magazinos.com
22nd Jun 20201:01 pmRNSTR-1: Notification of major holdings
18th Jun 202011:06 amRNSSecond Price Monitoring Extn
18th Jun 202011:00 amRNSPrice Monitoring Extension
3rd Jun 20201:27 pmRNSTR-1: Notification of major holdings
1st Jun 20202:05 pmRNSSecond Price Monitoring Extn
1st Jun 20202:00 pmRNSPrice Monitoring Extension
22nd May 20209:43 amRNSResult of General Meeting
5th May 202010:42 amRNSTR-1: Notification of major holdings
1st May 202010:58 amRNSPosting of Circular
1st Apr 20203:39 pmRNSCoronavirus and Business Update
23rd Mar 202012:19 pmRNSOn-line Platform Launched by Investee, Rosedog Ltd
20th Mar 20205:01 pmRNSNotification of major holdings
13th Mar 20207:00 amRNSSimultaneous exercise of five Option Agreements
27th Feb 202011:22 amRNSIssue of Equity and Directors' Dealing
27th Feb 20207:00 amRNSInterim Results
25th Feb 20209:16 amRNSNotification of major holdings
24th Feb 20207:00 amRNSCraven House signs 5 Non-binding Option Agreements
18th Feb 20202:54 pmRNSTR-1: Notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.